Patents by Inventor Silke Bandermann

Silke Bandermann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant as a vaccine
    Patent number: 9879268
    Abstract: The invention relates to a recombinant Mycobacterium cell for use as a vaccine.
    Type: Grant
    Filed: March 4, 2016
    Date of Patent: January 30, 2018
    Assignees: Vakzine Projekt Management GmbH, Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V.
    Inventors: Christine Desel, Stefan H. E. Kaufmann, Silke Bandermann, Leander Grode
  • RECOMBINANT MYCOBACTERIUM AS A VACCINE
    Publication number: 20160184419
    Abstract: The invention relates to a recombinant Mycobacterium cell for use as a vaccine.
    Type: Application
    Filed: March 4, 2016
    Publication date: June 30, 2016
    Applicants: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V., Vakzine Projekt Management GmbH
    Inventors: Christine DESEL, Stefan H.E. Kaufmann, Silke Bandermann, Leander Grode
  • Recombinant mycobacterium as a vaccine
    Patent number: 9328350
    Abstract: The invention relates to a recombinant Mycobacterium cell for use as a vaccine.
    Type: Grant
    Filed: December 21, 2011
    Date of Patent: May 3, 2016
    Assignees: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V., Vakzine Projekt Management GmbH
    Inventors: Christiane Desel, Stefan H. E. Kaufmann, Silke Bandermann, Leander Grode
  • Determination of the efficacy of an anti-mycobacterial vaccination
    Patent number: 8906389
    Abstract: The invention relates to methods and reagents for determining efficacy of vaccine, particularly of a tuberculosis vaccine.
    Type: Grant
    Filed: December 21, 2011
    Date of Patent: December 9, 2014
    Assignees: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V., Vakzine Projekt Management GmbH
    Inventors: Christiane Desel, Stefan H. E. Kaufmann, Silke Bandermann, Leander Grode
  • RECOMBINANT MYCOBCTERIUM AS A VACCINE
    Publication number: 20130337011
    Abstract: The invention relates to a recombinant Mycobacterium cell for use as a vaccine.
    Type: Application
    Filed: December 21, 2011
    Publication date: December 19, 2013
    Applicants: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V., Vakzine Projekt Management GmbH
    Inventors: Christiane Desel, Stefan H.E. Kaufmann, Silke Bandermann, Leander Grode
  • DETERMINATION OF THE EFFICACY OF AN ANTI-MYCOBACTERIAL VACCINATION
    Publication number: 20130280739
    Abstract: The invention relates to methods and reagents for determining efficacy of vaccine, particularly of a tuberculosis vaccine.
    Type: Application
    Filed: December 21, 2011
    Publication date: October 24, 2013
    Applicants: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V., Vakzine Projekt Management GmbH
    Inventors: Christiane Desel, Stefan H.E. Kaufmann, Silke Bandermann, Leander Grode